---
title: "Lanzhou Jincheng Pharmaceutical Co. Ltd — Ownership Dossier"
canonical: https://whiteintel.dev/entity/ed0f5a20-7b8a-4297-b6ae-3cfdddc8a877
json: https://whiteintel.dev/api/public/dossier/ed0f5a20-7b8a-4297-b6ae-3cfdddc8a877
identifier: gb-coh:91620102710212489X
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Lanzhou Jincheng Pharmaceutical Co. Ltd

**Type:** Company  
**Jurisdiction:** GB  
**Identifier:** `gb-coh:91620102710212489X`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/ed0f5a20-7b8a-4297-b6ae-3cfdddc8a877  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/ed0f5a20-7b8a-4297-b6ae-3cfdddc8a877  

## Ownership & control

### Holdings / subsidiaries

- **ANNIREN INTERNATIONAL LTD** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/540908f4-6e18-5de1-ac7c-3775d6d7d555

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Lanzhou Jincheng Pharmaceutical Co. Ltd**. Human view: https://whiteintel.dev/entity/ed0f5a20-7b8a-4297-b6ae-3cfdddc8a877 · Structured JSON: https://whiteintel.dev/api/public/dossier/ed0f5a20-7b8a-4297-b6ae-3cfdddc8a877._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._